Publicaciones en colaboración con investigadores/as de Centre National de la Recherche Scientifique (37)

2023

  1. The Cell Tracking Challenge: 10 years of objective benchmarking

    Nature Methods, Vol. 20, Núm. 7, pp. 1010-1020

2020

  1. Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 1

    HEMATO

2016

  1. Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma

    Cancer Investigation, Vol. 34, Núm. 1, pp. 39-44

  2. DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis

    American Journal of Human Genetics, Vol. 98, Núm. 4, pp. 680-696

  3. Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy

    European Journal of Immunology, Vol. 46, Núm. 3, pp. 513-522

2015

  1. Consensus nomenclature for CD8+ T cell phenotypes in cancer

    OncoImmunology, Vol. 4, Núm. 4

  2. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

    Nature Medicine, Vol. 21, Núm. 6, pp. 555-559

  3. Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12

    Cancer Research, Vol. 75, Núm. 3, pp. 497-507

2014

  1. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses

    Journal of Immunology, Vol. 193, Núm. 4, pp. 1787-1798

  2. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  3. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming

    Journal of Immunology, Vol. 193, Núm. 3, pp. 1151-1161

  4. Management of elderly patients with gliomas

    Oncologist, Vol. 19, Núm. 12, pp. 1258-1267

  5. Objective comparison of particle tracking methods

    Nature Methods, Vol. 11, Núm. 3, pp. 281-289

2013

  1. Classic and Contemporary Neural Tract-Tracing Techniques

    Diffusion MRI: From Quantitative Measurement to In vivo Neuroanatomy: Second Edition (Elsevier Inc.), pp. 359-399

  2. Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1944-1951

2012

  1. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma

    Nature Genetics, Vol. 44, Núm. 3, pp. 323-327

  2. Detection of IDH1 mutation in the plasma of patients with glioma

    Neurology, Vol. 79, Núm. 16, pp. 1693-1698

  3. Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: Comparative analysis of the Macdonald, RECIST, RANO, and RECIST F criteria

    Neuro-Oncology, Vol. 14, Núm. 5, pp. 667-673

2011

  1. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates

    PLoS ONE, Vol. 6, Núm. 2

  2. Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

    Liver International, Vol. 31, Núm. 10, pp. 1542-1553